日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phase II trial of post-operative radiotherapy with concurrent cisplatin plus panitumumab in patients with high-risk, resected head and neck cancer.

对高危头颈癌切除患者进行术后放疗联合顺铂加帕尼单抗治疗的 II 期试验

Ferris R L, Geiger J L, Trivedi S, Schmitt N C, Heron D E, Johnson J T, Kim S, Duvvuri U, Clump D A, Bauman J E, Ohr J P, Gooding W E, Argiris A

Negative predictive value of surveillance PET/CT in head and neck squamous cell cancer

PET/CT监测在头颈部鳞状细胞癌中的阴性预测值

McDermott, M; Hughes, M; Rath, T; Johnson, J T; Heron, D E; Kubicek, G J; Kim, S W; Ferris, R L; Duvvuri, U; Ohr, J P; Branstetter, B F